Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Signoretti

Showing results (131-140 of 257) with videos related to

Pageof 26
Sort By:
Cancer Research|May 28, 2009
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidneyRameen Beroukhim, Jean-Philippe Brunet, Arianna Di Napoli, et al.
Oncotarget|December 22, 2017
Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expressionAly-Khan A Lalani, Kathryn P Gray, Laurence Albiges, et al.
Cancer Immunology Research|May 28, 2015
Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell CarcinomaMarcella Callea, Laurence Albiges, Mamta Gupta, et al.
The Lancet. Oncology|December 11, 2012
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort studyFabio A B Schutz, Mark M Pomerantz, Kathryn P Gray, et al.
BMC Medical Research Methodology|December 24, 2014
Genomic investigation of etiologic heterogeneity: methodologic challengesColin B Begg, Venkatraman E Seshan, Emily C Zabor, et al.
Molecular Therapy Oncolytics|February 4, 2022
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse modelYufei Wang, Alicia Buck, Marion Grimaud, et al.
Science (New York, N.Y.)|August 27, 2016
pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent mannerJianping Guo, Abhishek A Chakraborty, Pengda Liu, et al.
Journal for Immunotherapy of Cancer|March 14, 2015
Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker studyAndré P Fay, Sabina Signoretti, Marcella Callea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor GenesCarla Calagua, Miriam Ficial, Caroline S Jansen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 14, 2016
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell CarcinomaAndre P Fay, Guillermo de Velasco, Thai H Ho, et al.
Pageof 26

Showing results (131-140 of 257) with videos related to

Sort By:
Pageof 26
Cancer Research|May 28, 2009
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidneyRameen Beroukhim, Jean-Philippe Brunet, Arianna Di Napoli, et al.
Oncotarget|December 22, 2017
Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expressionAly-Khan A Lalani, Kathryn P Gray, Laurence Albiges, et al.
Cancer Immunology Research|May 28, 2015
Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell CarcinomaMarcella Callea, Laurence Albiges, Mamta Gupta, et al.
The Lancet. Oncology|December 11, 2012
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort studyFabio A B Schutz, Mark M Pomerantz, Kathryn P Gray, et al.
BMC Medical Research Methodology|December 24, 2014
Genomic investigation of etiologic heterogeneity: methodologic challengesColin B Begg, Venkatraman E Seshan, Emily C Zabor, et al.
Molecular Therapy Oncolytics|February 4, 2022
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse modelYufei Wang, Alicia Buck, Marion Grimaud, et al.
Science (New York, N.Y.)|August 27, 2016
pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent mannerJianping Guo, Abhishek A Chakraborty, Pengda Liu, et al.
Journal for Immunotherapy of Cancer|March 14, 2015
Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker studyAndré P Fay, Sabina Signoretti, Marcella Callea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor GenesCarla Calagua, Miriam Ficial, Caroline S Jansen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 14, 2016
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell CarcinomaAndre P Fay, Guillermo de Velasco, Thai H Ho, et al.
Pageof 26